Statistics

Total Visits

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer65

Select a period of time:

Number of views in the range

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer27

Views

Views
January 20252
February 20252
March 202515
April 20253
May 20252
June 20253
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
United States12
Spain1
Hong Kong1
 

Top cities views

Views
Council Bluffs1
Hong Kong1
Portland1